期刊文献+

活血化瘀类中药注射剂用于骨伤科疾病的合理性探讨 被引量:11

Study on the rationality of the use of TCM injection of activating blood and resolving stasis in orthopedics disease
原文传递
导出
摘要 目的:调查广州中医药大学附属骨伤科医院中药注射剂使用情况,探讨其临床使用合理性,为临床合理用药提供依据。方法:随机抽查广州中医药附属骨伤科医院2016年1-6月间600份住院病历,将患者年龄、临床诊断、药品名称、用法、用量、溶媒、疗程等情况录入Excel表格中进行统计分析。结果:600份病历中,413例使用中药注射剂,463条医嘱,超说明书用药178条,其中,主要为超功能主治用药(占77.53%)。其次为剂量不足(12.92%),超溶媒(4.49%),超疗程(3.93%),超适用人群(1.12%)。结论:超说明书使用中药注射剂不能一概而论,应深入研究,分类对待。 Objective: To discuss the rationality of TCM injection in clinical use by investigating the clinical use of TCM injection in Traumatic and Orthopedic Hospital Affiliated to Guangzhou University of Chinese Medicine. Methods: Six hundreds hospitalized medical records in our hospitals were randomly inspected from January to June in 2016. The information including age of patients, clinical diagnosis, drug names, usage, dosage, solvent selection, course of treatment, and so on were entered into the Excel and then statistically analyzed. Results: Among 600 medical records, 413 cases of patients were prescribed the TCM injection. In 463 doctor's advices, the number of off-label use was 178, and the unlabeled medicine use accounted for 77.53%, not enough dose accounted for 12.92%, unreasonable solvent compatibility accounted for 4.49%, outside treatment course accounted for 3.93%, and outside target users accounted for 1.12%. Conclusion: The rationality of off-lable use in TCM injection can't treat as the same, and it should further study.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2017年第6期2494-2496,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
关键词 中药注射剂 超说明书用药 循证医学 活血化瘀类 骨伤科 合理性 TCM injection Off-lable use Evidence-based medicine Type of activating blood and resolving stasis Orthopedics Rationality
  • 相关文献

参考文献10

二级参考文献112

共引文献213

同被引文献112

引证文献11

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部